Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02739750 · ClinicalTrials.gov registry record
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 35
- Enrollment target
NCT02739750 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 35 participants.
The verdict
NCT02739750 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Chronic Kidney Disease (CKD) is associated with bone changes and very high fracture rates. A component of bone is marrow. Bone marrow fat is increased in patients with CKD compared to those in the normal population of the same age. It is not clear if there will be changes in the marrow fact content in those with CKD on Pioglitazone. In people with normal kidney function, thiazolidinedione group of drugs have had variable effects on bone marrow fat content, as measured by MRS. This is important as changes in marrow fat are likely related to changes in the bone in patients with chronic kidney disease.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02739750
The ClinicalTrials.gov registry entry for NCT02739750 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02739750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02739750 about?
NCT02739750 is a clinical study titled "Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease". Chronic Kidney Disease (CKD) is associated with bone changes and very high fracture rates. A component of bone is marrow. Bone marrow fat is increased in patients with CKD compared to those in the normal population of the same age. It is not clear if there will be changes in the marrow fact content ...
What is the current status of trial NCT02739750?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2016-01. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02739750?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02739750?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.